Compare AbCellera Biologics Inc (ABCL) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs GeneDx Holdings Corp — how do they compare? AbCellera Biologics Inc trades at $9.21 (market cap $2.99B), while GeneDx Holdings Corp trades at $82 (market cap $2.44B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| ABCL | WGS | |
|---|---|---|
Market Cap | $2.99B | $2.44B |
Sector | Health | Technology |
52-Week High | $9.76 | $167.51 |
52-Week Low | $2.78 | $34.51 |
Enterprise Value | $2.58B | $2.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
